Hall Render

DECEMBER 4, 2023

The Centers for Medicare & Medicaid Services (“CMS”) finalized significant updates to the Hospital Price Transparency regulation for the first time since the rule took effect on January 1, 2021. Hospitals must continue to include the payer-specific negotiated rates, along with the other standard charges.

Hospitals 52

Hospitals Compliance Patient Advocacy Medicare 52

Health Populi

JANUARY 7, 2019

An important example of this self-care approach is the evidence-based Ornish food regimen which is reimbursed by Medicare (as a form of cardiac rehabilitation). So at #CES2019, I’ve identified examples of technologies on the show floor to address heart health in each of these can-do, patient-empowering behavior changes.

FDA 67

FDA Patient Advocacy Medicare Medicare 67

HIT Consultant

MAY 24, 2022

More than a decade ago, CMS established the Continuity Assessment Record and Evaluation (CARE) set to measure the health and functional status of Medicare beneficiaries at the time of discharge and/or admission in post-acute care settings. While the scores these systems generate may well be accurate, they’re not particularly useful.

Nurses 52

Nurses Hospitals Patient Advocacy COVID-19 52

Hall Render

NOVEMBER 28, 2023

On November 1, 2023, the Centers for Medicare & Medicaid Services (“CMS”) posted a pre-publication copy of the Calendar Year (“CY”) 2024 Home Health Prospective Payment System Rate Update Final Rule (“2024 Final Rule”), which has since been filed in the Federal Register. Hospice Risk-Screening Category. Hospice 36-Month Rule.

Medicare 40

Medicare Medicare Payment Systems Medicaid 40

Health Populi

OCTOBER 8, 2019

This category comprised roughly one-third of the total waste in U.S. The Centers for Medicare and Medicaid Services (CMS) forecasts that prescription drug spending will be the fastest-growing cause of rising health spending by 2027. patients). medical spending. Political debates in this 2020 U.S.

Prescription Drug Pricing 104

Prescription Drug Pricing Medicare Medicare ACA 104

C&M Health Law

NOVEMBER 7, 2022

The EO comes two months after the president signed the Inflation Reduction Act (IRA) which promises to lower the cost of prescription drugs for many Medicare beneficiaries. This is not the first time that the White House will try to leverage CMMI’s testing authority to create models that would lower drug costs in Medicare.

Medicare 52

Medicare Medicare Medicaid Medicaid 52

Health Law Advisor

JULY 21, 2023

On June 22, 2023, the Centers for Medicare & Medicaid Services (CMS) announced its proposed “Transitional Coverage for Technologies” (TCET) pathway—the Biden administration’s highly anticipated take on a mechanism to expedite coverage for certain devices designated by the U.S. Food and Drug Administration (FDA) as breakthrough devices. [1]

FDA 52

FDA Medicare Medicare Patient Advocacy 52